Ask AI
ProCE Banner Activity

An Expert’s Guide to ASCO GI 2023: A Preview of the Top Abstracts

Conference Coverage
Clinical Thought

In this commentary, expert faculty highlight key studies being presented at the upcoming ASCO Gastrointestinal Cancers Symposium. CCO&rsquo s Independent Conference Coverage of ASCO GI 2023 will have the information you need to understand and integrate the latest oncology data into your clinical practice.

Released: January 19, 2023

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by educational grants from

Bristol Myers Squibb

Incyte Corporation

Merck Sharp & Dohme Corp.

Seagen Inc.

Faculty Disclosure

Primary Author

Christopher Lieu, MD, FASCO

Professor of Medicine
Division of Medical Oncology
University of Colorado Cancer Center
Aurora, Colorado

Christopher H. Lieu, MD: researcher: Merck.

Rachna Shroff, MD, MS, FASCO

Chief, Division of Hematology/Oncology, UA COM-T
Associate Director of Clinical Investigations, UACC
Professor of Medicine
University of Arizona Cancer Center (UACC)
University of Arizona College of Medicine - Tucson (UA-COM-T)
Tucson, Arizona

Rachna Shroff, MD, MS: consultant/advisor/speaker: AstraZeneca, Boehringer Ingelheim, Clovis, Genentech, Incyte, Merck, QED Therapeutics, Servier, Taiho, Syros, Zymeworks Biopharm; researcher: Bayer, Bristol-Myers Squibb, Exelixis, IMV, LOXO, Merck, Novocure, Nucana, Pieris, QED Therapeutics, Rafael, Seagen, Taiho.